SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-012187
Filing Date
2018-05-09
Accepted
2018-05-09 12:05:18
Documents
89
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q 03312018 mygn-10q_20180331.htm 10-Q 2468431
2 EX-31.1 mygn-ex311_6.htm EX-31.1 15846
3 EX-31.2 mygn-ex312_8.htm EX-31.2 16325
4 EX-32.1 mygn-ex321_7.htm EX-32.1 6514
  Complete submission text file 0001564590-18-012187.txt   10088119

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mygn-20180331.xml EX-101.INS 2657724
6 XBRL TAXONOMY EXTENSION SCHEMA mygn-20180331.xsd EX-101.SCH 57848
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mygn-20180331_cal.xml EX-101.CAL 80772
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mygn-20180331_def.xml EX-101.DEF 158663
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20180331_lab.xml EX-101.LAB 432709
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20180331_pre.xml EX-101.PRE 346239
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 18817408
SIC: 2835 In Vitro & In Vivo Diagnostic Substances